Bank of America’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bank of America’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-175,000	Closed	-$4.26M	–	8091
2023 Q1	$4.26M	Buy	+175,000	New	+$3.83M	﹤0.01%	3674
2017 Q1	–	Sell	-20,000	Closed	-$97K	–	7319
2016 Q4	$97K	Buy	20,000 +16,100	+413%	+$478K	﹤0.01%	5642
2016 Q3	$180K	Buy	+3,900	New	+$220K	﹤0.01%	5177
2015 Q2	–	Sell	-50,000	Closed	-$2.33M	–	7467
2015 Q1	$2.33M	Buy	+50,000	New	+$2.6M	﹤0.01%	3105

Bank of America's ISEE Position: Q3 2023 in Review

Bank of America sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,637,560 shares — an estimated $64.4M sold.

Bank of America first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $64.4M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Bank of America reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bank of America sold 1,637,560 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $64.4M.
Bank of America first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
Bank of America's IVERIC bio, Inc. Common Stock position peaked at $64.4M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.